UBS Group AG - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 28 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,939
-28.1%
6,679
-3.6%
0.00%
Q4 2022$4,087
+308.7%
6,927
+360.6%
0.00%
Q3 2022$1,0000.0%1,504
+50.4%
0.00%
Q2 2022$1,000
-83.3%
1,000
-28.9%
0.00%
Q1 2022$6,000
-87.2%
1,407
-76.4%
0.00%
Q4 2021$47,0005,9530.00%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
First PREMIER Bank 807,535$4760.14%
Warberg Asset Management LLC 370,370$218,5180.03%
METEORA CAPITAL, LLC 134,524$79,3560.02%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 149,774$88,3520.02%
SILVER OAK SECURITIES, INCORPORATED 51,941$310.01%
Veritable, L.P. 506,513$298,7920.01%
Shaolin Capital Management LLC 236,621$1400.00%
Elgethun Capital Management 14,796$9,1710.00%
LGL PARTNERS, LLC 23,000$13,5680.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$49,5520.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders